Herley (HRLY) Reports Earnings for First Quarter of Fiscal 2010
LANCASTER, Pa., Dec. 10 /PRNewswire-FirstCall/ — Herley Industries, Inc. (Nasdaq: HRLY – News) today reported financial results for its First Quarter of Fiscal Year 2010.
Net sales for the first quarter of fiscal 2010 were $47.7 million compared to $35.3 million for the first quarter of fiscal 2009. Income from continuing operations was $3.6 million, or $.26 per diluted share, compared to a loss from continuing operations of $.9 million, or $(.07) per diluted share, last year. The loss from discontinued operations last year of $.5 million, or $(.03) per diluted share, resulted from the sale of the ICI business in November 2008. Net income for the first quarter was $3.6 million, or $.26 per diluted share, compared to a net loss of $1.3 million, or $(.10) per diluted share, last year.
The Company’s EBITDA for the first quarter of 2010 was $6.9 million compared to $1.1 million last year. The Company’s Adjusted EBITDA for the first quarter of 2010 was $7.4 million compared to $1.7 million last year. Adjusted EBITDA is defined as operating income plus the impact of foreign exchange transactions, excluding interest, taxes, depreciation and amortization, and litigation costs.
The Company reported a revenue increase of $12.4 million in the first quarter of fiscal 2010 compared to last year. The 35% increase was primarily related to increased deliveries under major production programs. In addition, an increase of approximately $2.0 million in sales was due to the inclusion of three months of Eyal’s revenues in the first quarter of fiscal 2010 compared to the inclusion of two months of its revenues for the comparable prior quarter. Gross profit in the quarter was $13.3 million (27.9% gross profit margin) compared to $6.6 million (18.7% gross profit margin) last year, an increase of $6.7 million. The increase in gross profit and gross profit margin during fiscal 2010 was principally a result of leveraging our fixed costs on the sales increase as well as anticipated improvements in margins related to manufacturing efficiencies and a favorable program mix.
Selling and administrative (“S&A”) expenses for the first quarter were $7.7 million, or 16.1% of sales, compared to $7.3 million, or 20.7% of sales, last year. The $.4 million increase in S&A expenses was primarily attributable to an increase of approximately $.9 million in commissions and related sales expenses associated with the increase in sales and approximately $.2 million due to the inclusion of a full quarter of Eyal’s expenses since its acquisition in last year’s first quarter, partially offset by approximately $.7 million related to cost reductions, including payroll-related expenses.
The Company reported operating income during the first quarter of fiscal 2010 of $5.1 million compared to an operating loss of $.7 million last year. The prior-year quarter included a gain on the sale of certain assets of approximately $.6 million.
At November 1, 2009, the Company’s balance sheet is strong, with total cash and cash equivalents of $13.8 million, working capital of $90.8 million and long-term debt, exclusive of settlement commitments, of $20.2 million. Capital expenditures were $1.4 million for the first quarter of fiscal 2010 compared to $2.0 million last year.
Richard F. Poirier, Chief Executive Officer and President, commented, “We are very pleased by the results of this quarter. We maintain a strong backlog, and are continuing to realize the benefits of transitioning from development to full production on major programs. We are also looking to expand into new programs, and continue to concentrate on strengthening relationships with our customers.”
Richard Poirier, Chief Executive Officer and President, will host a conference call on December 11, 2009 at 10:00 a.m. Eastern Time to discuss the financial results for the First Quarter of Fiscal Year 2010, which ended November 1, 2009. To join the conference call, dial 1 (888) 425-4188, referencing Conference ID #42650178.
A taped replay of the call will be available on December 11, 2009 at 11:00 a.m. through December 18, 2009 at 11:59 p.m. Eastern Time. To listen to the replay, dial: 1 (800) 642-1687 (U.S.) or 1 (706) 645-9291 (International), and Conference ID #42650178.
In addition, the conference call will be broadcast live over the Internet and can be accessed through the following URL: http://www.videonewswire.com/event.asp?id=64188. To listen to the live call on the Internet, go to the web site at least 15 minutes early to register, download and install any necessary audio software.
Herley Industries, Inc. is a leader in the design, development and manufacture of microwave technology solutions for the defense, aerospace and medical industries worldwide. Based in Lancaster, PA, Herley has seven manufacturing locations and approximately 1,000 employees. Additional information about the Company can be found on the Internet at www.herley.com
Safe Harbor Statement – Except for the historical information contained herein, this release may contain forward-looking statements. Such statements are inherently subject to risks and uncertainties. Forward-looking statements involve various important assumptions, risks, uncertainties and other factors which could cause our actual results to differ materially from those expressed in such forward-looking statements. Forward-looking statements in this discussion can be identified by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “plan,” “intend,” “may,” “should” or the negative of these terms or similar expressions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievement. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors including but not limited to, competitive factors and pricing pressures, changes in legal and regulatory requirements, cancellation or deferral of customer orders, technological change or difficulties, difficulties in the timely development of new products, difficulties in manufacturing, commercialization and trade difficulties and current economic conditions, including the potential for significant changes in US defense spending under the new Administration which could affect future funding of programs and allocations within the budget to various programs as well as the factors set forth in this report and in our public filings with the Securities and Exchange Commission.
For information at Herley, contact: Peg Guzzetti Tel: (717) 397-2777 Investor Relations www.herley.com
HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
November 1,
2009 August 2,
(Unaudited) 2009
----------- ----
ASSETS
Current Assets:
Cash and cash equivalents $13,832 $14,820
Trade accounts receivable, net 30,015 28,687
Costs incurred and income
recognized in excess
of billings on uncompleted
contracts and claims 6,226 10,396
Inventories, net 57,471 57,804
Deferred income taxes 18,171 19,380
Other current assets 3,770 2,816
Total Current Assets 129,485 133,903
Property, plant and
equipment, net 32,877 32,872
Goodwill 43,722 43,722
Intangibles, net 9,167 9,619
Deferred income taxes 7,616 7,571
Other assets 550 598
--- ---
Total Assets $223,417 $228,285
======== ========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Current portion of long-term debt $1,386 $1,595
Current portion of
employment settlement
agreements 1,284 7,400
Current portion of
litigation settlements 971 954
Accounts payable and accrued
expenses 22,366 26,447
Billings in excess of costs
incurred and income recognized on
uncompleted contracts 101 261
Accrual for contract losses 2,290 3,440
Advance payments on
contracts 10,256 12,698
------ ------
Total Current Liabilities 38,654 52,795
Long-term debt, net of
current portion 18,807 12,246
Long-term portion of
employment settlement
agreements 2,469 2,827
Other long-term liabilities 8,190 8,361
Total Liabilities 68,120 76,229
------ ------
Commitments and Contingencies
Shareholders' Equity:
Common stock, $.10 par
value; authorized
20,000,000 shares;
issued and outstanding
13,689,024 at November 1,
2009 and 13,719,926 at August 2,
2009 1,369 1,372
Additional paid-in capital 102,799 103,113
Retained earnings 51,433 47,882
Accumulated other
comprehensive loss (304) (311)
---- ----
Total Shareholders' Equity 155,297 152,056
------- -------
Total Liabilities and
Shareholders' Equity $223,417 $228,285
======== ========
HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
Thirteen weeks ended
--------------------
November November
1, 2,
2009 2008
---- ----
Net sales $47,679 $35,344
------- -------
Cost and expenses:
Cost of products sold 34,392 28,741
Selling and administrative expenses 7,681 7,323
Gain on sale of assets - (618)
Litigation costs 540 558
--- ---
42,613 36,004
Operating income (loss) 5,066 (660)
----- ----
Other (expense) income:
Interest income 11 18
Interest expense (165) (223)
Foreign exchange transaction losses (42) (360)
--- ----
(196) (565)
---- ----
Income (loss) from continuing
operations
before income taxes 4,870 (1,225)
Provision (benefit) for income taxes 1,319 (342)
----- ----
Income (loss) from continuing
operations 3,551 (883)
----- ----
Discontinued operations:
Loss from operations of discontinued
subsidiary - (734)
Benefit for income taxes - (278)
--- ----
Loss from discontinued operations - (456)
--- ----
Net income (loss) $3,551 $(1,339)
====== =======
Earnings (loss) per common share -
Basic
Income (loss) from continuing
operations $.26 $(.07)
Loss from discontinued operations - (.03)
--- ----
Net income (loss) - basic $.26 $(.10)
==== =====
Basic weighted average shares 13,704 13,525
====== ======
Earnings (loss) per common share -
Diluted
Income (loss) from continuing
operations $.26 $(.07)
Loss from discontinued operations - (.03)
--- ----
Net income (loss) - diluted $.26 $(.10)
==== =====
Diluted weighted average shares 13,878 13,525
====== ======
HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
Thirteen weeks ended
--------------------
November November
1, 2,
2009 2008
---- ----
Cash flows from operating activities:
Net income (loss) $3,551 $(1,339)
------ -------
Adjustments to reconcile net
income (loss) to
net cash provided by (used in)
operating activities:
Depreciation and amortization 1,845 2,148
Gain on sale of fixed assets - (618)
Impairment of goodwill of
discontinued subsidiary - 1,000
Stock-based compensation costs 124 148
Excess tax benefit from
exercises of stock options - (19)
Imputed interest on employment
and litigation settlement
liabilities 45 96
Foreign exchange transaction
losses - 360
Inventory valuation reserve
charges 299 400
Warranty reserve charges 542 343
Deferred tax provision
(benefit) 1,162 (620)
Changes in operating assets
and liabilities:
Cash of discontinued
subsidiary - (712)
Trade accounts receivable (1,304) 896
Costs incurred and income
recognized in excess
of billings on uncompleted
contracts and claims 4,158 4,786
Inventories, net 35 (375)
Other current assets (952) (180)
Accounts payable and accrued
expenses (4,639) (4,093)
Billings in excess of costs
incurred and
income recognized on
uncompleted contracts (158) 252
Accrual for contract losses (1,150) (55)
Litigation settlement payments (2,000) -
Employment settlement payments (6,502) (330)
Advance payments on contracts (443) (117)
Other, net (124) (850)
---- ----
Total adjustments (9,062) 2,460
------ -----
Net cash (used in) provided by
operating activities (5,511) 1,121
------ -----
Cash flows from investing
activities:
Acquisition of business, net
of cash acquired - (30,010)
Capital expenditures (1,398) (2,044)
------ ------
Net cash used in investing
activities (1,398) (32,054)
------ -------
Cash flows from financing
activities:
Borrowings under bank line of
credit 7,000 20,000
Borrowings - term loan - 10,000
Proceeds from exercise of
stock options - 38
Excess tax benefit from
exercises of stock options - 19
Payments of long-term debt (642) (441)
Payments under bank line of
credit - (1,000)
Purchase of treasury stock (441) -
---- ---
Net cash provided by financing
activities 5,917 28,616
----- ------
Effect of exchange rate
changes on cash 4 (81)
--- ---
Net decrease in cash and cash
equivalents (988) (2,398)
Cash and cash equivalents at
beginning of period 14,820 14,347
------ ------
Cash and cash equivalents at
end of period $13,832 $11,949
======= =======
HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP MEASURES
EBITDA AND ADJUSTED EBITDA
(Unaudited)
The following is a reconciliation of operating income, which is a GAAP measure of our operating results, to EBITDA and Adjusted EBITDA. Management believes that the presentation of EBITDA and Adjusted EBITDA is appropriate to provide additional information about the Company’s results. EBITDA and Adjusted EBITDA are not presentations made in accordance with GAAP, are not measures of financial performance or condition, liquidity or profitability of the Company, and should not be considered as an alternative to (1) net income, operating income or any other performance measures determined in accordance with GAAP or (2) operating cash flows determined in accordance with GAAP. Additionally, EBITDA and Adjusted EBITDA are not intended to be measures of free cash flow for management’s discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, capital expenditures and debt service requirements.
For the
Thirteen
Weeks Ended
===========
November November
(in thousands) 1, 2,
-------- --------
2009 2008
---- ----
Operating income (loss) - as
reported $5,066 $(660)
Depreciation and
amortization 1,845 2,148
Foreign exchange transaction
losses (42) (360)
=== ====
EBITDA 6,869 1,128
Litigation costs 540 558
--- ---
Adjusted EBITDA $7,409 $1,686
====== ======
TraderPower Featured Companies
- Annovis Bio Inc. (NYSE: ANVS)
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Fintech Ecosystem Development Corp. (NASDAQ: FEXD)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
Recent Posts
- $ECGI InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Says Success of Allon Equestrian Apparel Line at AETA Is ‘Pivotal Moment’
- $MUX InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources
- $RFHRF InvestorNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Shares Update on Completed, Upcoming Exploration Activities
- $SFWJ Hemp Industry Says Missouri Governor ‘Overreached’ When Banning Hemp Intoxicants
- $INM InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
- $SCNI InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
- $ANVS Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast
- $FLGC CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space
Recent Comments
Archives
- August 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009